By slicing and dicing the data, the study confirms MITRA-FR as an outlier and emphasizes the need for careful patient selection.
The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...